Press release

Frost & Sullivan honors DSM with the Growth Excellence Leadership Award for medical device coatings

Exton PA, US, 20 Aug 2014 16:00 CEST

DSM, a global leader in biomedical materials science and regenerative medicine, today announced that Frost & Sullivan, a global growth consulting firm, has honored the Company with the Growth Excellence Leadership Award for Medical Device Coatings. Based on its recent analysis of the Medical Device Coatings market, Frost & Sullivan determined that DSM, through its strong brand recognition and customizable product offering, outperforms its competitors in six selected categories. These include, total customer experience, ownership experience, service experience, above-market growth, growth strategy excellence, and growth sustainability.

In a market with heavy competition, DSM has not only maintained top line growth above the industry average of 7 to 10 percent, but has done so rapidly, as it entered the medical device coatings market only 7 years ago. Frost & Sullivan also recognized DSM’s unique positioning as a total solutions provider, working with customers throughout the complete continuum of medical device development. Further, the award distinguishes DSM as a company that is committed to addressing future market needs through its best-in-class technical performance, customer intimacy, and coating service plant support.

We are delighted to receive the Growth Excellence Leadership Award by Frost & Sullivan and be recognized for our superior products, services and unwavering commitment to quality,” said Dr. Hinke Malda, Global Director Medical Coatings, DSM Biomedical. “DSM will continue to set itself apart in the medical device coatings market by maintaining close relationships with our partners and staying ahead of the market through the Company’s resolute focus on innovation.”

“DSM strives to optimize relationships with its customers and other players in the value chain. From strategic procurement of raw-materials to customer product evaluations and device maker collaborations, DSM addresses multiple links in the market,” said Reuben Sequeira, Research Analyst, Frost & Sullivan.

According to Frost & Sullivan, DSM’s customer-centric strategies are one of the key ingredients to its success. Coupled with its cross-functional expertise and its commitment to value-added partnerships and acquisitions, DSM is well positioned to remain the “total solutions provider” to the medical device coatings market.

For more information about DSM’s Coatings portfolio please visit: DSM – Hydrophilic lubricious and antifouling coatings.

For more information

Kwittken & Company

+1 646 747 7161

Read more

  • Our products

    Our products

    DSM portfolio of innovative biomedical materials and process manufacturing technologies: Biomedical Polyethylenes, Biomedical polyurethanes, Collagen Technology, Device Development, and Extracellular Matrix (ECM) Technology. Learn more.

  • The markets we serve

    The markets we serve

    DSM Biomedical offers the broadest portfolio of biomedical materials and manufacturing across market applications, including orthopedics, ophthalmology, neurology, cardiology, diabetes, wound, and continence care.

This site uses cookies to store information on your computer.

Learn more